FIBRICOR (Caraco Pharma, Inc.)


Welcome to the PulseAid listing for the FIBRICOR drug offered from Caraco Pharma, Inc.. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Caraco Pharma, Inc.
NON-PROPRIETARY NAME: Fenofibric Acid
SUBSTANCE NAME: FENOFIBRIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Peroxisome Proliferator Receptor alpha Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-08-14
END MARKETING DATE: 0000-00-00


FIBRICOR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFIBRICOR from Caraco Pharma, Inc.
LABELER NAME: Caraco Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 35(mg/1)
START MARKETING DATE: 2009-08-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49708-101_7a94885b-62b6-4db9-8d01-f594be8dba13
PRODUCT NDC: 49708-101
APPLICATION NUMBER: NDA022418

Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Trilipix
Actavis Pharma, Inc.fenofibric acid
Alembic Pharmaceuticals Inc.Fenofibric Acid
Alembic Pharmaceuticals LimitedFenofibric Acid
AR Scientific, Inc.FIBRICOR
Aralez Pharmaceuticals US Inc.FIBRICOR
Caraco Pharma, Inc.FIBRICOR
Halton LaboratoriesFenofibric Acid
Impax GenericsFenofibric Acid
Mutual Pharmaceutical Company, Inc.Fenofibric Acid
Mylan Pharmaceuticals Inc.Fenofibric Acid
Physicians Total Care, Inc.Trilipix
Tribute Pharmaceuticals US, Inc.FIBRICOR
Zydus Pharmaceuticals USA IncFenofibric Acid